Mark J. Taisey

General Counsel en AMGEN INC. .

Health Technology

Consumer Services

Perfil

Mark J.
Taisey is currently the Senior VP-Global Regulatory Affairs & Strategy at Amgen, Inc. He previously worked as the Chairman-Regulatory Steering Group at Pharmaceutical Research & Manufacturers of America from 2019 to 2020, and as an Executive Director at Pfizer Inc. from 2002 to 2007.
Mr. Taisey completed his undergraduate degree at Rochester Christian University.

Cargos activos de Mark J. Taisey

Empresas	Cargo	Inicio
AMGEN INC.	General Counsel	01/01/2014

Todos los cargos activos de Mark J. Taisey

Antiguos cargos conocidos de Mark J. Taisey.

Empresas	Cargo	Fin
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Corporate Officer/Principal	01/01/2020
PFIZER, INC.	Director/Board Member	01/01/2007

Ver el detalle de la experiencia de Mark J. Taisey.

Formación de Mark J. Taisey.

Rochester Christian University

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Mark J. Taisey.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	2
AMGEN INC.	Health Technology
PFIZER, INC.	Health Technology

Empresas privadas	1
Pharmaceutical Research & Manufacturers of America Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.	Health Technology